caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1215036868

Jessamyn MelnicoffCRNP (NURSE PRACT)

PRACTICETEMPLESee all providers at this practice →
Nurse PractitionerPhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 390027
Hospital
REFERRAL NETWORK

Where Jessamyn Melnicoff's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
3259
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
TEMPLE UNIVERSITY HOSPITAL, INC3878
Marissa Blum
Rheumatology · Philadelphia, PA
2429
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
2030
Philip Cohen
Rheumatology · Philadelphia, PA
1217
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
90
Unique beneficiaries
—
Total services
153
Distinct HCPCS
3
Medicare payment
$8K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 7,939 Nurse Practitioner providers in PA — above median (cohort median 235).
PRESCRIBING · PART D · 2024
Total Rx claims
2,463
Beneficiaries
—
Total drug cost
$6.5M
Distinct drugs
36
Brand share
46.8%
Top prescribed drugs
Etanercept272 claims
Adalimumab264 claims
Methotrexate Sodium216 claims
Tizanidine Hcl197 claims
Gabapentin182 claims
QUALITY · MIPS · 2024
Final MIPS score
81.2
Quality
49.7
Cost
74.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.26%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.